ICU Medical PE Ratio 2010-2023 | ICUI
Current and historical p/e ratio for ICU Medical (ICUI) from 2010 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. ICU Medical PE ratio as of May 16, 2024 is 22.47.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| ICU Medical PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2024-05-16 | 106.27 | 0.00 | |
| 2023-12-31 | 99.74 | $-1.23 | 0.00 |
| 2023-09-30 | 119.01 | $-1.17 | 0.00 |
| 2023-06-30 | 178.19 | $-2.02 | 0.00 |
| 2023-03-31 | 164.96 | $-1.92 | 0.00 |
| 2022-12-31 | 157.48 | $-3.12 | 0.00 |
| 2022-09-30 | 150.60 | $-1.56 | 0.00 |
| 2022-06-30 | 164.39 | $0.42 | 391.40 |
| 2022-03-31 | 222.64 | $2.04 | 109.14 |
| 2021-12-31 | 237.34 | $4.74 | 50.07 |
| 2021-09-30 | 233.38 | $5.04 | 46.31 |
| 2021-06-30 | 205.80 | $4.77 | 43.14 |
| 2021-03-31 | 205.44 | $4.34 | 47.34 |
| 2020-12-31 | 214.49 | $4.03 | 53.22 |
| 2020-09-30 | 182.76 | $3.78 | 48.35 |
| 2020-06-30 | 184.31 | $3.86 | 47.75 |
| 2020-03-31 | 201.77 | $4.04 | 49.94 |
| 2019-12-31 | 187.12 | $4.70 | 39.81 |
| 2019-09-30 | 159.60 | $3.38 | 47.22 |
| 2019-06-30 | 251.91 | $2.15 | 117.17 |
| 2019-03-31 | 239.33 | $2.53 | 94.60 |
| 2018-12-31 | 229.63 | $1.32 | 173.96 |
| 2018-09-30 | 282.75 | $4.01 | 70.51 |
| 2018-06-30 | 293.65 | $4.01 | 73.23 |
| 2018-03-31 | 252.40 | $0.70 | 360.57 |
| 2017-12-31 | 216.00 | $3.33 | 64.86 |
| 2017-09-30 | 185.85 | $1.54 | 120.68 |
| 2017-06-30 | 172.50 | $2.62 | 65.84 |
| 2017-03-31 | 152.70 | $5.47 | 27.92 |
| 2016-12-31 | 147.35 | $3.57 | 41.27 |
| 2016-09-30 | 126.38 | $3.36 | 37.61 |
| 2016-06-30 | 112.75 | $3.25 | 34.69 |
| 2016-03-31 | 104.10 | $3.10 | 33.58 |
| 2015-12-31 | 112.78 | $2.74 | 41.16 |
| 2015-09-30 | 109.50 | $2.87 | 38.15 |
| 2015-06-30 | 95.66 | $2.31 | 41.41 |
| 2015-03-31 | 93.14 | $1.86 | 50.08 |
| 2014-12-31 | 81.90 | $1.69 | 48.46 |
| 2014-09-30 | 64.18 | $2.09 | 30.71 |
| 2014-06-30 | 60.81 | $2.39 | 25.44 |
| 2014-03-31 | 59.88 | $2.49 | 24.05 |
| 2013-12-31 | 63.71 | $2.64 | 24.13 |
| 2013-09-30 | 67.93 | $2.60 | 26.13 |
| 2013-06-30 | 72.06 | $2.70 | 26.69 |
| 2013-03-31 | 58.95 | $2.85 | 20.68 |
| 2012-12-31 | 60.93 | $2.80 | 21.76 |
| 2012-09-30 | 60.48 | $3.24 | 18.67 |
| 2012-06-30 | 53.38 | $3.07 | 17.39 |
| 2012-03-31 | 49.16 | $3.11 | 15.81 |
| 2011-12-31 | 45.00 | $3.15 | 14.29 |
| 2011-09-30 | 36.80 | $2.61 | 14.10 |
| 2011-06-30 | 43.70 | $2.61 | 16.74 |
| 2011-03-31 | 43.78 | $2.50 | 17.51 |
| 2010-12-31 | 36.50 | $2.23 | 16.37 |
| 2010-09-30 | 37.29 | $2.01 | 18.55 |
| 2010-06-30 | 32.17 | $1.78 | 18.07 |
| 2010-03-31 | 34.45 | $1.60 | 21.53 |
| 2009-12-31 | 36.44 | $1.77 | 20.59 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $2.546B | $2.259B |
| ICU Medical, Inc. develops, manufactures and sells innovative medical devices used in vascular therapy, oncology and critical care applications. They are one of the world's leading pure-play infusion therapy companies, with global operations and a wide-ranging product portfolio that includes IV solutions, IV smart pumps, dedicated and non-dedicated IV sets and needlefree connectors, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. In addition, they manufacture automated pharmacy IV compounding systems with workflow technology, closed systems transfer devices for hazardous IV drugs, and cardiac monitoring systems to optimize patient fluid levels. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $181.948B | 23.83 |
| Stryker (SYK) | United States | $126.472B | 30.29 |
| Medtronic (MDT) | Ireland | $112.493B | 15.93 |
| Boston Scientific (BSX) | United States | $109.225B | 34.79 |
| EssilorLuxottica (ESLOY) | France | $102.697B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $43.832B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.401B | 28.03 |
| ResMed (RMD) | United States | $32.412B | 30.43 |
| Terumo (TRUMY) | Japan | $26.228B | 37.04 |
| Koninklijke Philips (PHG) | Netherlands | $25.491B | 19.75 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.889B | 15.90 |
| Baxter (BAX) | United States | $18.054B | 12.84 |
| Insulet (PODD) | United States | $12.646B | 56.08 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.240B | 0.00 |
| Demant (WILYY) | Denmark | $10.234B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.583B | 28.08 |
| BellRing Brands (BRBR) | United States | $7.715B | 36.13 |
| Lantheus Holdings (LNTH) | United States | $5.517B | 13.75 |
| Haemonetics (HAE) | United States | $4.900B | 24.24 |
| GN Store Nord (GNNDY) | Denmark | $4.400B | 24.71 |
| Perrigo (PRGO) | Ireland | $4.120B | 12.49 |
| Prestige Consumer Healthcare (PBH) | United States | $3.300B | 15.79 |
| Envista Holdings (NVST) | United States | $3.241B | 13.38 |
| QuidelOrtho (QDEL) | United States | $3.011B | 16.71 |
| Neogen (NEOG) | United States | $2.881B | 27.71 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.816B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $2.741B | 54.29 |
| TG Therapeutics (TGTX) | United States | $2.739B | 77.04 |
| Agios Pharmaceuticals (AGIO) | United States | $1.997B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.858B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.752B | 51.36 |
| InMode (INMD) | Israel | $1.583B | 8.42 |
| Warby Parker (WRBY) | United States | $1.558B | 0.00 |
| Owens & Minor (OMI) | United States | $1.546B | 13.47 |
| AdaptHealth (AHCO) | United States | $1.308B | 9.74 |
| National Vision Holdings (EYE) | United States | $1.258B | 40.03 |
| BioLife Solutions (BLFS) | United States | $1.058B | 0.00 |
| AtriCure (ATRC) | United States | $1.053B | 0.00 |
| Canopy Growth (CGC) | Canada | $1.004B | 0.00 |
| Evolus (EOLS) | United States | $0.829B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.739B | 15.73 |
| Cresco Labs (CRLBF) | United States | $0.722B | 0.00 |
| Quanterix (QTRX) | United States | $0.684B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.639B | 15.02 |
| Valneva SE (VALN) | France | $0.616B | 0.00 |
| PetIQ (PETQ) | United States | $0.577B | 18.86 |
| Jin Medical (ZJYL) | China | $0.527B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.510B | 0.00 |
| Surmodics (SRDX) | United States | $0.479B | 29.96 |
| ZimVie (ZIMV) | United States | $0.455B | 38.79 |
| Biote (BTMD) | United States | $0.435B | 8.33 |
| OraSure Technologies (OSUR) | United States | $0.398B | 12.82 |
| Aurora Cannabis (ACB) | Canada | $0.388B | 0.00 |
| Cerus (CERS) | United States | $0.375B | 0.00 |
| Zynex (ZYXI) | United States | $0.350B | 47.87 |
| MacroGenics (MGNX) | United States | $0.295B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.294B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.269B | 26.61 |
| TriSalus Life Sciences (TLSI) | United States | $0.251B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.244B | 15.39 |
| Omeros (OMER) | United States | $0.242B | 0.00 |
| Veru (VERU) | United States | $0.215B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.204B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.200B | 0.00 |
| High Tide (HITI) | Canada | $0.190B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.170B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.169B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.156B | 75.00 |
| InterCure (INCR) | Israel | $0.149B | 25.23 |
| Jushi Holdings (JUSHF) | United States | $0.139B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.136B | 19.32 |
| Cellectar Biosciences (CLRB) | United States | $0.120B | 0.00 |
| Fonar (FONR) | United States | $0.103B | 8.84 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.097B | 0.00 |
| MariMed (MRMD) | United States | $0.095B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.092B | 0.00 |
| Brainsway (BWAY) | Israel | $0.090B | 0.00 |
| Chimerix (CMRX) | United States | $0.088B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.076B | 0.00 |
| Safety Shot (SHOT) | United States | $0.072B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.060B | 3.91 |
| Rockwell Medical (RMTI) | United States | $0.052B | 0.00 |
| Apyx Medical (APYX) | United States | $0.049B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.046B | 0.00 |
| United-Guardian (UG) | United States | $0.042B | 15.37 |
| Bright Green (BGXX) | United States | $0.040B | 0.00 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| ImmuCell (ICCC) | United States | $0.038B | 0.00 |
| Exagen (XGN) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.022B | 0.00 |
| Agape ATP (ATPC) | $0.019B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.018B | 0.00 |
| Flora Growth (FLGC) | United States | $0.017B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.013B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.011B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Sharps Technology (STSS) | United States | $0.003B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |